HOW IT WORKS

RESET® is a thin, flexible 60 cm sleeve that is endoscopically implanted within the small intestine by a trained physician. The implant secures itself with an anchoring mechanism at the upper portion of the small intestine. Placement is performed as an outpatient procedure that does not require incisions.

Once in place, RESET® conforms to the shape and movement of the intestine and may begin to work immediately by creating a physical barrier between receptors in the intestinal wall and food that has been shown to directly affect key hormone levels.

WHAT IT DOES

Non-US Clinical studies have shown that RESET® creates changes in gut hormones that mimic mechanisms similar to Roux-en-Y gastric bypass (RYGB)¹ and reduces cardiovascular risks² and liver fibrosis through positive clinical outcomes.

Clinical data suggests RESET® improves insulin resistance and glycemic control and reduces weight in patients with type 2 diabetes and obesity.¹

RESET® HAS BEEN SHOWN TO:

• · Lower blood sugar levels (HbA1c) ¹ ²
• · Increase weight loss and lower BMI ¹ ²
• · Reduce cardiovascular risk²

The most commonly reported complications of RESET® are gastrointestinal in nature. They include nausea, vomiting, and upper abdominal pain of mild to moderate severity and are mostly prevalent in the early days and weeks following RESET® placement. Uncommon risks include liver abscess, device-related bleeding, device migration, pancreatitis, or other infections, any of which may result in endoscopic or surgical removal of the device. As with all endoscopic and/or implant procedures, serious injury or death can occur.

REMOVAL

Treatment with RESET® may last up to 9 months but should not exceed 9 months. Removal of RESET® is conducted through an endoscopic outpatient procedure under general anesthesia.